ClinicalTrials.gg
RecruitingNCT05767658SUPERSONICUpdated Jan 12, 2026

Support Via Online Social Networks to Promote Safe Infant Care Practices

An interventional study of Safe Sleep and Breastfeeding in Breastfeeding, Infant Death and Sudden Infant Death Syndrome Without Mention of Autopsy, sponsored by University of Virginia. Recruiting at 1 site in United States. Open to female participants. Per ClinicalTrials.gov, last updated 2026-01-12.

Sponsored by University of Virginia · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Jul 2026, 4 months ago, but the record still lists the study as recruiting.
  • Started Mar 2024; still recruiting 2 years 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
3,000
Allocation
Randomized
Sex
Female
01

Study summary

This study aims to improve adherence to American Academy of Pediatrics safe sleep (SS) recommendations and improve rates of initiation and duration of partial and exclusive breastfeeding (BF); and reduce Black/White disparities in these practices through the use of private Facebook groups providing a) evidence-based education through videos and other multi-media supporting best practices and b) an online community and social network of other pregnant WIC clients and new parents.

02

Conditions studied

  • Breastfeeding
  • Infant Death
  • Sudden Infant Death Syndrome Without Mention of Autopsy

Keywords

  • Safe Sleep
  • Breastfeeding
  • Social Media
03

In context

Breast Feeding

1,081 studies on the registry are indexed under Breast Feeding; 217 are open to participants now.

This study's planned enrollment of 3,000 is above the median of 100 across 844 interventional studies indexed under Breast Feeding.

Browse Breast Feeding studies →

Lead sponsor

University of Virginia is the lead sponsor of 675 studies on the registry; 138 are open to participants now.

Of its 61 completed or terminated interventional studies of FDA-regulated products, 42 (69%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Currently enrolled in WIC, or it not, then have either Medicaid or no health insurance
  • Must be English speaking
  • Must be pregnant and less than 30 weeks gestation
  • Must live in the United States
  • Must have regular access to Facebook and short message service (SMS) texting (mobile phone)

Exclusion criteria

Exclusion Criteria:

  • Not planning to live in same home as infant after birth.
  • Prenatal diagnosis expected to impact on infant care practices in a manner not compatible with study goals, including to feeding any breastmilk or supine infant sleep positioning.
  • Known or reported mental health or other issues that would preclude custody of the infant or being able to participate in the process.
  • Meets the definition of a minor according to applicable state law.
  • Participants who consent to participation in the study, must complete the Agile Onboarding process before they reach 30+0 weeks gestation.
  • Currently or previously received a TodaysBaby educational program (randomized to a TodaysBaby program through either the SMARTER, or SUPERSONIC study), either in their current or a previous pregnancy.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Participant)
Enrollment
3,000 participants (estimated)

Study arms

  • Experimental
    Safe Sleep

    Participants will be part of a private Facebook group from approximately 32 weeks gestation to 6 months postpartum. The Facebook group will provide a) evidence-based education through videos and other multi-media supporting best practices for infant safe sleep and b) an online community and social network of other pregnant WIC clients and new parents

    Behavioral: Safe Sleep

  • Experimental
    Breastfeeding

    Participants will be part of a private Facebook group from approximately 32 weeks gestation to 6 months postpartum. The Facebook group will provide a) evidence-based education through videos and other multi-media supporting best practices for breastfeeding and b) an online community and social network of other pregnant WIC clients and new parents

    Behavioral: Breastfeeding

  • Experimental
    Safe Sleep and Breastfeeding

    Participants will be part of a private Facebook group from approximately 32 weeks gestation to 6 months postpartum. The Facebook group will provide a) evidence-based education through videos and other multi-media supporting best practices for infant safe sleep and breastfeeding, and b) an online community and social network of other pregnant WIC clients and new parents

    Behavioral: Safe Sleep · Behavioral: Breastfeeding

  • Active comparator
    Early Brain Development and Parent -Child Relationships

    Participants will be part of a private Facebook group from approximately 32 weeks gestation to 6 months postpartum. The Facebook group will provide a) evidence-based education through videos and other multi-media supporting best practices for early brain development and parent-child interactions (control intervention) and b) an online community and social network of other pregnant WIC clients and new parents.

    Behavioral: Early Brain Development and Parent-Child Relationships

Interventions

  • BehavioralSafe Sleep

    Participants will be part of a private Facebook group from approximately 32 weeks gestation to 6 months postpartum. The Facebook group will provide a) evidence-based education through videos and other multi-media supporting best practices for infant safe sleep and b) an online community and social network of other pregnant WIC clients and new parents.

  • BehavioralBreastfeeding

    Participants will be part of a private Facebook group from approximately 32 weeks gestation to 6 months postpartum. The Facebook group will provide a) evidence-based education through videos and other multi-media supporting best practices for breastfeeding and b) an online community and social network of other pregnant WIC clients and new parents.

  • BehavioralEarly Brain Development and Parent-Child Relationships

    Participants will be part of a private Facebook group from approximately 32 weeks gestation to 6 months postpartum. The Facebook group will provide a) evidence-based education through videos and other multi-media supporting best practices for early brain development and parent-child interactions (control intervention) and b) an online community and social network of other pregnant WIC clients and new parents.

06

What researchers measure

Primary outcomes

  1. Exclusive infant supine sleep position in the previous two weeks

    An investigator-developed maternal survey will be used to assess infant's usual sleep position during the previous two weeks with categorical responses of back, stomach, side, and other, with the proportion of infants using exclusive supine sleep position as the primary outcome measure.

    Time frame: Between 2 and 6 months

  2. Infant sleep location (exclusive room sharing without bed sharing) in the previous two weeks

    An investigator-developed maternal survey will be used to assess the infant's usual sleep location during the previous two weeks with categorical responses of room sharing without bed sharing, room sharing with bed sharing, no room sharing and no bed sharing, with the proportion of infants exclusively room sharing without bed sharing as the primary outcome measure.

    Time frame: Between 2 and 6 months

  3. Soft bedding use in the previous two weeks

    An investigator-developed maternal survey will be used to assess soft bedding placed in and around the infant (while sleeping) during the previous two weeks with categorical responses of Yes or No.

    Time frame: Between 2 and 6 months

  4. Breastmilk feeding in the previous two weeks

    An investigator-developed maternal survey will be used to assess whether the infant was breast fed during the previous two weeks with categorical responses of exclusively breast fed, partially breast fed, or not breast fed.

    Time frame: Between 2 and 6 months

Secondary outcomes

  1. Usual infant sleep position in the previous two weeks

    An investigator-developed maternal survey will be used to assess infant's usual sleep position during the previous two weeks with categorical responses of back, stomach, side, and other.

    Time frame: Between 2 and 6 months

  2. . Usual infant sleep location in the previous two weeks

    An investigator-developed maternal survey will be used to assess the infant's usual sleep location during the previous two weeks with categorical responses of room sharing without bed sharing, room sharing with bed sharing, no room sharing and no bed sharing.

    Time frame: Between 2 and 6 months

  3. Pacifier use in the previous two weeks

    An investigator-developed maternal survey will be used to assess the infant's pacifier use during the previous two weeks with categorical responses of Yes or No.

    Time frame: Between 2 and 6 months

07

Study locations

1 of 1 sites recruiting
  • Boston University Medical Campus
    Boston, Massachusetts 02118, United States
    Recruiting
08

References and documents

Publications

  • Carlin RF, Parker MG, Kellams AL, Hauck FR, Kerr S, Cornwell BT, Kiviniemi MT, Geller N, Boguszewski KE, Corwin MJ, Colson ER, Moon RY. Delivering safe sleep and breastfeeding education to pregnant and new mothers through private Facebook groups: study protocol for a 4-armed randomized controlled trial. BMC Pediatr. 2026 Apr 22;26(1):528. doi: 10.1186/s12887-026-06900-9. PubMed 42021196 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2024 (actual). Primary completion is estimated for Jul 2026, 28 months after the start.

Of 502 non-industry interventional studies with no phase under Breast Feeding, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 28 months is above that.

Counting every sponsor, half of 510 studies reached it within 12 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 2, 2023
First posted
Mar 14, 2023
StartActual
Mar 1, 2024
Primary completionEst.
Jul 1, 2026
CompletionEst.
Jul 1, 2026
Last update
Jan 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05767658
Responsible party
Rachel Moon, MD (Professor, Department of Pediatrics, University of Virginia) — Principal investigator
First posted
Mar 14, 2023
Start date
Mar 1, 2024
Primary completion
Jul 1, 2026 (estimated)
Completion
Jul 1, 2026 (estimated)
Last update
Jan 12, 2026

Study contacts

Katherine Boguszewski, MA
Contact
Keb5un@uvahealth.org
434-243-9663
Rachel Y Moon, MD
principal investigator · University of Virginia School of Medicine

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion